We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PX
101
DELISTED
Praxair Inc
PX
$108M 0.19%
749,745
+2,521
+0.3% +$392K
AGN
102
DELISTED
Allergan plc
AGN
$108M 0.19%
641,714
+109,118
+20% +$18.3M
TFC icon
103
Truist Financial
TFC
$64B
$105M 0.19%
2,025,816
-56,773
-3% -$3.06M
GSLC icon
104
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.5B
$104M 0.19%
1,944,948
+582,067
+43% +$31.9M
ADSK icon
105
Autodesk
ADSK
$52.6B
$103M 0.19%
822,654
+10,144
+1% +$1.21M
VEA icon
106
Vanguard FTSE Developed Markets ETF
VEA
$236B
$103M 0.18%
2,325,314
+34,732
+2% +$1.58M
CRM icon
107
Salesforce
CRM
$158B
$98.7M 0.18%
848,403
+62,712
+8% +$7.2M
RDS.A
108
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$98.6M 0.18%
1,544,791
-31,550
-2% -$2.08M
MDT icon
109
Medtronic
MDT
$112B
$97.8M 0.18%
1,219,364
+89,217
+8% +$7.36M
FDX icon
110
FedEx
FDX
$75.4B
$97.4M 0.17%
405,608
+159,998
+65% +$40.5M
BTI icon
111
British American Tobacco
BTI
$128B
$97M 0.17%
1,681,284
-40,816
-2% -$2.57M
WY icon
112
Weyerhaeuser
WY
$18.4B
$96.4M 0.17%
2,755,450
+171,955
+7% +$6.07M
SBUX icon
113
Starbucks
SBUX
$120B
$96.2M 0.17%
1,661,845
+473,978
+40% +$27.4M
IBM icon
114
IBM
IBM
$224B
$94.9M 0.17%
646,695
+40,340
+7% +$6.1M
APC
115
DELISTED
Anadarko Petroleum
APC
$94.8M 0.17%
1,570,072
+180,240
+13% +$10.6M
BIIB icon
116
Biogen
BIIB
$30.7B
$92.9M 0.17%
339,161
+3,866
+1% +$1.2M
NVS icon
117
Novartis
NVS
$297B
$92.5M 0.17%
1,277,090
+3,458
+0.3% +$263K
BDX icon
118
Becton Dickinson
BDX
$48.2B
$92.3M 0.17%
436,732
+64,113
+17% +$14M
BND icon
119
Vanguard Total Bond Market
BND
$158B
$91.3M 0.16%
1,142,392
+94,675
+9% +$7.58M
MA icon
120
Mastercard
MA
$493B
$89.7M 0.16%
511,988
+26,226
+5% +$4.48M
EPD icon
121
Enterprise Products Partners
EPD
$81.7B
$88.9M 0.16%
3,632,565
+281,215
+8% +$7.49M
PYPL icon
122
PayPal
PYPL
$50.5B
$87.6M 0.16%
1,155,172
+18,244
+2% +$1.45M
WELL icon
123
Welltower
WELL
$171B
$87.2M 0.16%
1,601,127
+35,002
+2% +$1.98M
VEU icon
124
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$87M 0.16%
1,599,939
+319,638
+25% +$17.8M
VCSH icon
125
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$86.7M 0.16%
1,105,104
+166,500
+18% +$13.1M

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.